Search Results - "Rüffer, J. U."

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly) by Ballova, V., Rüffer, J.-U., Haverkamp, H., Pfistner, B., Müller-Hermelink, H. K., Dühmke, E., Worst, P., Wilhelmy, M., Naumann, R., Hentrich, M., Eich, H. T., Josting, A., Löffler, M., Diehl, V., Engert, A.

“…In contrast to younger patients, the prognosis of elderly patients with advanced Hodgkin's disease (HD) has not improved substantially over the last 20 years…”
Get full text

Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG) by RÜFFER, J. U, FLECHTNER, H, TRALLS, P, JOSTING, A, SIEBER, M, LATHAN, B, DIEHL, V

“…Although treatment regimens for Hodgkin's lymphoma have become more sophisticated, little is known about the prevalence of fatigue in long-term survivors…”
Get full text

Adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis: Analyses of a large-scale observational study by Kuipers, J. G., Koller, M., Zeman, F., Müller, K., Rüffer, J. U.

“…Background Disabilities in daily living and quality of life are key endpoints for evaluating the treatment outcome for rheumatoid arthritis (RA). Factors…”
Get full text

BEACOPP and COPP ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - Results of the German Hodgkin Study Group by Rüffer, J. U., Ballova, V., Glossmann, J., Sieber, M., Franklin, J., Nogova, L., Diehl, V., Josting, A.

“…Patients with early stage favorable Hodgkin's disease who relapse after extended field radiotherapy have satisfactory results. We retrospectively analysed…”
Get full text

BEACOPP: A new regimen for advanced Hodgkin's disease by Diehl, V., Franklin, J., Hasenclever, D., Tesch, H., Pfreundschuh, M., Lathan, B., Paulus, U., Sieber, M., Rüffer, J.-U., Sextro, M., Engert, A., Wolf, J., Hermann, R., Holmer, L., Stappert-Jahn, U., Winnerlein-Trump, E., Wulf, G., Krause, S., Glunz, A., von Kalle, K., Bischoff, H., Haedicke, C., Dühmke, E., Georgii, A., Loeffler, M.

“…The BEACOPP chemotherapy regimen for advanced Hodgkin's disease employs a rearranged schedule permitting a shortened three-week cycle. With haematological…”
Get full text

Quality of life assessment in Hodgkin's disease : A new comprehensive approach: First experiences from the EORTC/GELA and GHSG trials by FLECHTNER, H, RÜFFER, J.-U, HENRY-AMAR, M, MELLINK, W. A. M, SIEBER, M, FERME, C, EGHBALI, H, JOSTING, A, DIEHL, V

Get full text

Report of the workshop on clinical trials by Rüffer, J.-U., Sieber, M.

“…During the Third International Symposium, a leading panel of experts in the field discussed the current most prominent problems in the treatment of Hodgkin's…”
Get full text

Fatigue — Diagnostik, klinische Implikationen und Therapie by Rüffer, J. U., Flechtner, H.

Get full text

Tumor-related fatigue - an underestimated problem by Rüffer, J U

Get more information

Comprehensive Implementation of Shared Decision Making in a Neuromedical Center Using the SHARE TO CARE Program by Stolz-Klingenberg, Constanze, Bünzen, Claudia, Coors, Marie, Flüh, Charlotte, Stürner, Klarissa Hanja, Wehkamp, Kai, Clayman, Marla L, Scheibler, Fueloep, Rüffer, Jens Ulrich, Schüttig, Wiebke, Sundmacher, Leonie, Berg, Daniela, Geiger, Friedemann

“…SHARE TO CARE (S2C) is a comprehensive, multi-module implementation program for shared decision making (SDM). It is currently applied at the University…”
Get full text

Tumor-Fatigue-Sprechstunde der Bayerischen Krebsgesellschaft e.V: Was passiert da eigentlich? Teil II: Beratung by Fischer, I., Rüffer, J. U., Besseler, M., Bojko, P., Heußner, P., Koller, M., Milani, V., Riedner, C., Rinas, N., Schlimok, G., Schneider, E., Heim, M. E.

Get full text

Zwei Jahre Tumor-Fatigue-Sprechstunde der Bayerischen Krebsgesellschaft e. V: Was wurde bisher erreicht und wohin geht die Reise? by Fischer, I., Besseler, M., Bojko, P., Heim, M. E., Koller, M., Milani, V., Riedner, C., Rinas, N., Rüffer, J. U., Schneider, E., Heußner, P., Schlimok, G.

Get full text

Report of the workshop on clinical trials. GHSG. German Hodgkin Study Group by Rüffer, J U, Sieber, M

“…During the Third International Symposium, a leading panel of experts in the field discussed the current most prominent problems in the treatment of Hodgkin's…”
Get full text

Cancer fatigue syndrome by Rüffer, J U, Flechtner, H, Heim, M, Schwarz, R, Weis, J

“…Tumour-related fatigue, which occurs in almost all tumour patients under therapy--very often even years after a successful therapy--has a considerable impact…”
Get more information

Der Film in der Patientenaufklärung: Unverzichtbares Medium oder Luxus? by Rüffer, J.U.

“…Zusammenfassung Die umfassende Aufklärung der Patienten ist heute allgemein anerkannter Standard in der medizinischen Versorgung. Diese eigentlich noch junge…”
Get full text

Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group by Flechtner, H, Rüffer, J U, Henry-Amar, M, Mellink, W A, Sieber, M, Fermé, C, Eghbali, H, Josting, A, Diehl, V

“…Previous reports from available trials have dealt with negative long-term sequelae in Hodgkin's disease (HD) survivors. There is, however, a lack of…”
Get full text

Quality of life assessment in Hodgkin's disease: A new comprehensive approach by Flechtner, H., Rüffer, J.-U., Henry-Amar, M., Mellink, W. A. M., Sieber, M., Fermé, C., Eghbali, H., Josting, A., Diehl, V.

“…Previous reports from available trials have dealt with negative long-term sequelae in Hodgkin's disease (HD) survivors. There is, however, a lack of…”
Get full text

Fatigue – Tumorerschöpfung: Ein unabwendbares Schicksal? by Rüffer, J.U., Adamietz, I.A.

“…Zusammenfassung Hintergrund Obwohl die subjektive Todesbedrohung von Betroffenen und Nichtbetroffenen kaum abgenommen hat, überleben heute mehr als die Hälfte…”
Get full text

BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group by Diehl, V, Franklin, J, Hasenclever, D, Tesch, H, Pfreundschuh, M, Lathan, B, Paulus, U, Sieber, M, Rüffer, J U, Sextro, M, Engert, A, Wolf, J, Hermann, R, Holmer, L, Stappert-Jahn, U, Winnerlein-Trump, E, Wulf, G, Krause, S, Glunz, A, von Kalle, K, Bischoff, H, Haedicke, C, Dühmke, E, Georgii, A, Loeffler, M

“…The BEACOPP chemotherapy regimen for advanced Hodgkin's disease employs a rearranged schedule permitting a shortened three-week cycle. With haematological…”
Get full text

Psychoonkologie: Konzepte und Aufgaben einer jungen Fachdisziplin by Weis, J., Schumacher, A., Blettner, G., Determann, M., Reinert, E., Rüffer, J.U., Werner, A., Weyland, P.

Get full text